Literature DB >> 26101797

An integrated view of cisplatin-induced nephrotoxicity and ototoxicity.

Takatoshi Karasawa1, Peter S Steyger2.   

Abstract

Cisplatin is one of the most widely-used drugs to treat cancers. However, its nephrotoxic and ototoxic side-effects remain major clinical limitations. Recent studies have improved our understanding of the molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. While cisplatin binding to DNA is the major cytotoxic mechanism in proliferating (cancer) cells, nephrotoxicity and ototoxicity appear to result from toxic levels of reactive oxygen species and protein dysregulation within various cellular compartments. In this review, we discuss molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. We also discuss potential clinical strategies to prevent nephrotoxicity and ototoxicity and their current limitations.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cisplatin; Intracellular mechanisms; Nephrotoxicity; Ototoxicity

Mesh:

Substances:

Year:  2015        PMID: 26101797      PMCID: PMC4516600          DOI: 10.1016/j.toxlet.2015.06.012

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  137 in total

1.  Histological effects of co-administration of an ACTH((4-9)) analogue, ORG 2766, on cisplatin ototoxicity in the albino guinea pig.

Authors:  R M Cardinaal; J C de Groot; E H Huizing; J E Veldman; G F Smoorenburg
Journal:  Hear Res       Date:  2000-06       Impact factor: 3.208

2.  Probing the pore of the auditory hair cell mechanotransducer channel in turtle.

Authors:  H E Farris; C L LeBlanc; J Goswami; A J Ricci
Journal:  J Physiol       Date:  2004-06-04       Impact factor: 5.182

3.  Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells.

Authors:  R H Lee; J M Song; M Y Park; S K Kang; Y K Kim; J S Jung
Journal:  Biochem Pharmacol       Date:  2001-10-15       Impact factor: 5.858

4.  Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity.

Authors:  Hyung-Jin Kim; Jeong-Han Lee; Se-Jin Kim; Gi Su Oh; Hae-Dalma Moon; Kang-Beom Kwon; Channy Park; Byung Hyun Park; Ho-Kyun Lee; Sang-Young Chung; Raekil Park; Hong-Seob So
Journal:  J Neurosci       Date:  2010-03-17       Impact factor: 6.167

Review 5.  Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.

Authors:  Penelope R Brock; Kristin R Knight; David R Freyer; Kathleen C M Campbell; Peter S Steyger; Brian W Blakley; Shahrad R Rassekh; Kay W Chang; Brian J Fligor; Kaukab Rajput; Michael Sullivan; Edward A Neuwelt
Journal:  J Clin Oncol       Date:  2012-04-30       Impact factor: 44.544

6.  Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4.

Authors:  Samson Jamesdaniel; Donald Coling; Sneha Hinduja; Dalian Ding; Jun Li; Linda Cassidy; Gail M Seigel; Jun Qu; Richard Salvi
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

7.  Direct effects of reactive oxygen species on cochlear outer hair cell shape in vitro.

Authors:  W J Clerici; D L DiMartino; M R Prasad
Journal:  Hear Res       Date:  1995-04       Impact factor: 3.208

8.  Protection of renal cells from cisplatin toxicity by cell cycle inhibitors.

Authors:  Peter M Price; Robert L Safirstein; Judit Megyesi
Journal:  Am J Physiol Renal Physiol       Date:  2003-09-09

9.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

10.  Targeting mitochondrial DNA with a platinum-based anticancer agent.

Authors:  Simon P Wisnovsky; Justin J Wilson; Robert J Radford; Mark P Pereira; Maria R Chan; Rebecca R Laposa; Stephen J Lippard; Shana O Kelley
Journal:  Chem Biol       Date:  2013-10-31
View more
  127 in total

1.  Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats.

Authors:  Mohamed M Abdel-Daim; Yasser S El-Sayed; Mabrouk Abd Eldaim; Abdelazim Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

2.  Necroptosis and Apoptosis Contribute to Cisplatin and Aminoglycoside Ototoxicity.

Authors:  Douglas Ruhl; Ting-Ting Du; Elizabeth L Wagner; Jeong Hwan Choi; Sihan Li; Robert Reed; Kitae Kim; Michael Freeman; George Hashisaki; John R Lukens; Jung-Bum Shin
Journal:  J Neurosci       Date:  2019-02-07       Impact factor: 6.167

3.  Amelioration of cisplatin-induced acute kidney injury by recombinant neutrophil gelatinase-associated lipocalin.

Authors:  Qing Ma; Shiva R Devarajan; Prasad Devarajan
Journal:  Ren Fail       Date:  2016-09-08       Impact factor: 2.606

Review 4.  Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.

Authors:  Corné J Kros; Peter S Steyger
Journal:  Cold Spring Harb Perspect Med       Date:  2019-11-01       Impact factor: 6.915

Review 5.  A Review of Cisplatin-Associated Ototoxicity.

Authors:  Jessica Paken; Cyril D Govender; Mershen Pillay; Vikash Sewram
Journal:  Semin Hear       Date:  2019-04-26

Review 6.  Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.

Authors:  Blessy George; Melanie S Joy; Lauren M Aleksunes
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-12

7.  Pichia fermentans originates apoptosis in human oral squamous cell carcinoma by over-expressing BAX and CASP 9 genes.

Authors:  Hasan Bagherpour Shamloo; Arman Shahabi; Zahra Aghazadeh; Ahmad Yari Khosroushahi
Journal:  Cytotechnology       Date:  2020-04-06       Impact factor: 2.058

Review 8.  Inherited and acquired disorders of magnesium homeostasis.

Authors:  Matthias Tilmann Florian Wolf
Journal:  Curr Opin Pediatr       Date:  2017-04       Impact factor: 2.856

9.  Prevalence and Predictors of Frailty in Childhood Cancer Survivors and Siblings: A Report From the Childhood Cancer Survivor Study.

Authors:  Samah Hayek; Todd M Gibson; Wendy M Leisenring; Jennifer L Guida; Maria Monica Gramatges; Philip J Lupo; Rebecca M Howell; Kevin C Oeffinger; Smita Bhatia; Kim Edelstein; Melissa M Hudson; Leslie L Robison; Paul C Nathan; Yutaka Yasui; Kevin R Krull; Gregory T Armstrong; Kirsten K Ness
Journal:  J Clin Oncol       Date:  2019-12-04       Impact factor: 44.544

10.  Protective effects of dioscin against cisplatin-induced nephrotoxicity via the microRNA-34a/sirtuin 1 signalling pathway.

Authors:  Yimeng Zhang; Xufeng Tao; Lianhong Yin; Lina Xu; Youwei Xu; Yan Qi; Xu Han; Shasha Song; Yanyan Zhao; Yuan Lin; Kexin Liu; Jinyong Peng
Journal:  Br J Pharmacol       Date:  2017-07-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.